Codes / ICD10CM / A52.19

A52.19 Other symptomatic neurosyphilis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other symptomatic neurosyphilis

Summary

Other symptomatic neurosyphilis is a late-stage manifestation of syphilis infection that affects the nervous system, resulting in clinical symptoms. It occurs when the bacterium Treponema pallidum invades the central nervous system, leading to neurological dysfunction. This condition can involve the brain, spinal cord, or peripheral nerves and may present with a range of neurological signs and symptoms not classified under more specific neurosyphilis subtypes.

Causes

Other symptomatic neurosyphilis is caused by the bacterium Treponema pallidum. It develops when the infection progresses untreated through earlier stages, allowing the bacteria to invade and damage nervous system tissues. The condition may arise years after initial exposure if syphilis is not adequately treated during primary, secondary, or latent phases.

Risk Factors

  • Untreated or inadequately treated syphilis
  • Prolonged latency period without medical intervention
  • Immune system compromise (e.g., HIV infection)
  • High-risk sexual behaviors or exposure to infected individuals

Symptoms

  • Neurological deficits: cognitive impairment, memory loss, or personality changes
  • Motor dysfunction: weakness, ataxia, or gait abnormalities
  • Sensory disturbances: numbness, tingling, or pain in extremities
  • Headache, dizziness, or visual disturbances
  • Seizures or altered mental status in severe cases

Diagnosis

Diagnosis involves a combination of clinical evaluation, cerebrospinal fluid (CSF) analysis, and serological testing. CSF may show elevated protein, pleocytosis, or positive syphilis-specific tests. Neuroimaging (e.g., MRI) may reveal abnormalities, and neurological exams assess functional deficits. Confirmation requires correlation of symptoms with laboratory and clinical findings.

Treatment Options

Treatment typically involves intravenous penicillin G, the standard therapy for neurosyphilis. Dosage and duration depend on disease severity and patient factors. Adjunctive therapies may address symptoms (e.g., pain management, seizure control). Follow-up includes repeat CSF testing to monitor treatment response.

Prognosis and Follow-Up

Prognosis varies based on the extent of neurological damage and timeliness of treatment. Early intervention may improve outcomes, but some deficits may be irreversible. Regular follow-up with CSF testing and clinical assessments is essential to ensure treatment efficacy and detect recurrence.

Complications

Potential complications include permanent neurological damage, cognitive decline, motor dysfunction, and increased risk of other infections due to immune compromise. Untreated cases may progress to severe disability or life-threatening conditions.

Lifestyle & Prevention

Prevention focuses on safe sexual practices, regular screening for syphilis, and prompt treatment of early-stage infections. Avoiding high-risk behaviors and using barrier protection can reduce transmission. For those with syphilis, completing prescribed treatment and follow-up is critical.

When to Seek Professional Help

Seek medical attention if experiencing neurological symptoms (e.g., persistent headache, numbness, cognitive changes) or if diagnosed with syphilis without prior treatment. Early evaluation is crucial to prevent progression and complications.

Tips for Medical Coders

Document the specific neurological manifestations and clinical findings to support the "other symptomatic" classification. Ensure differentiation from more specific neurosyphilis subtypes (e.g., tabes dorsalis) and confirm the absence of those conditions. Include details on CSF analysis, imaging, and treatment to validate code assignment.

Book a walkthrough

A52.19 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.